Lynn Morris is an expert in Infectiology at University of the Witwatersrand (South Africa). Lynn Morris has authored 304 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 1,058 (community average: 125). How the SLR is computed.

LeadR Profile

Lynn Morris University of the Witwatersrand South Africa
1 058 ScienceLeadR Reputation 1058
Network Map

Infectiology

Subspecialties: Immunology - Genetics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1983 - 2026

Source: PubMed

University of the Witwatersrand

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 304

Citations

Citations: 26 541 1st author: 7 Last author: 63 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.
PMID 42708883 — hiv-1, broadly neutralizing antibodies, epitopes, viruses, diagnosis, communicable diseases
J Infect Dis20260
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.
PMID 41932899 — recombination, genetic, broadly neutralizing antibodies, antibodies, neutralizing, hiv, viruses, genes, rev, therapeutics, infections
Nat Commun20260
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.
PMID 41279072 — broadly neutralizing antibodies, hiv, mutation
bioRxiv20251
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody.
PMID 41018010 — serum, antibodies, neutralizing, hiv
medRxiv20251
Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012-2017.
PMID 41017033 — drug resistance, fungal, communicable disease control, antimicrobial stewardship, sepsis, azoles, mycoses, fungi, antifungal agents, candida, infections
Emerg Infect Dis20250

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 4
N/A 2
Phase 1 2
Phase 1/Phase 2 2

By status:

Completed 8
Unknown 2

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 4
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map